METAVIA INC. Earnings Per Share (Basic)
METAVIA INC. (MTVA) reported Earnings Per Share (Basic) of -$0.90 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- METAVIA INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.90.
- METAVIA INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.79.
- METAVIA INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.14.
- METAVIA INC. earnings per share, basic for the quarter ending 2025-06-30 was -$2.87.
- METAVIA INC. earnings per share, basic for fiscal 2025 was -$7.35.
- METAVIA INC. earnings per share, basic for fiscal 2024 was -$39.13.
- METAVIA INC. earnings per share, basic for fiscal 2023 was -$2.46.
- METAVIA INC. earnings per share, basic for fiscal 2022 was -$43.42.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.90 10-Q · filed 2026-08-06 | -$1.69 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$0.79 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$7.35 10-K · filed 2026-03-26 | |||||||
| 2025-09-30 | -$0.14 10-Q · filed 2025-11-06 | -$0.63 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$2.87 10-Q · filed 2026-08-06 | -$0.26 10-Q · filed 2025-08-07 | -$6.59 10-Q · filed 2026-08-06 | -$0.60 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | -$3.93 10-Q · filed 2026-05-14 | -$0.36 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | -$39.13 10-K · filed 2026-03-26 | -$3.56 10-K · filed 2025-03-20 | ||||||
| 2024-09-30 | -$0.55 10-Q · filed 2025-11-06 | -$3.24 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | -$1.85 10-Q · filed 2025-08-07 | -$3.19 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | -$1.32 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | -$2.46 10-K · filed 2025-03-20 | |||||||
| 2023-09-30 | -$0.75 10-Q · filed 2024-11-07 | -$0.09 10-Q · filed 2023-11-13 | -$1.41 10-Q · filed 2024-11-07 | -$0.18 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | -$0.15 10-Q · filed 2024-08-14 | -$0.02 10-Q · filed 2023-08-09 | -$0.66 10-Q · filed 2024-08-14 | -$0.08 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | -$0.51 10-Q · filed 2024-05-09 | -$0.06 10-Q · filed 2023-05-12 | ||||||
| 2022-12-31 | -$43.42 10-K · filed 2024-03-28 | -$5.43 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | -$3.50 10-Q · filed 2023-11-13 | -$10.45 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | -$3.72 10-Q · filed 2023-08-09 | -$0.12 10-Q · filed 2022-08-12 | -$6.95 10-Q · filed 2023-08-09 | -$0.23 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | -$3.24 10-Q · filed 2023-05-12 | -$0.11 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | -$19.81 10-K · filed 2023-03-30 | -$0.66 10-K · filed 2022-03-31 | ||||||
| 2021-09-30 | -$4.66 10-Q · filed 2022-11-14 | -$0.16 10-Q · filed 2021-11-15 | -$14.58 10-Q · filed 2022-11-14 | -$0.49 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | -$0.18 10-Q · filed 2022-08-12 | -$0.33 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.15 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | -$1.83 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | -$0.19 10-Q · filed 2021-11-15 | -$0.63 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |